News
9h
The Punch on MSNGloria Izu’s innovative strides laudedAn award-winning biomedical researcher, entrepreneur and consultant, Gloria Izu, is set to create opportunities for researchers, entrepreneurs, and young professionals in the fields of biotech, ...
Regeneron Pharmaceuticals, Inc. and Society for Science (the Society) announced that Adam Kovalcík, 19, of Dulovce, Slovakia, ...
Pfizer and RemeGen's HER2 antibody-drug conjugate delivered positive phase 3 results in a bladder cancer trial in China. | ...
New research shows the technology’s potential to help find treatments for diseases that have baffled scientists.
Emrosi commercial launch initiated for the treatment of inflammatory lesions of rosacea in adults Fortress subsidiary Checkpoint Therapeutics to be acquired by Sun Pharma; special meeting of Checkpoin ...
The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.
HCW Biologics Inc. (the "Company” or "HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on ...
Fortress Biotech, Inc. (Nasdaq: FBIO) ("Fortress”), an innovative biopharmaceutical company focused on acquiring and ...
Simulations Plus, Inc. ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the ...
A very different kind of “hog farm” being built by United Therapeutics Corp. on the edge of Stewartville to raise gene-edited ...
Terrance Cole, President Trump's nominee for DEA Administrator, largely sidestepped questions from two Democratic senators ...
New Drug Application (NDA) for hyperphosphatemia in chronic kidney disease patients on dialysis under review by FDA with PDUFA target action date of June 28, 2025; ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results